As we pass the halfway point for the SDGs, many of the goals are worryingly off track and progress on 85% of the target indicators has stalled or even reversed. Through our information, products and people, RELX remains committed to advancing the Goals. Here are some of the ways that we continue to support their achievement.
Rare Disease Education: Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Editor: Kelsey LaFayette, DNP, RN, FNP-C
Rare Disease Education: Infantile Neuroaxonal Dystrophy
Editor: Kelsey LaFayette, DNP, RN, FNP-C
This study supports SDG 3 by providing data on the prevalence and characteristics of occult hepatitis B virus infection.
This article supports SDG 3 by providing global prevalence data on occult HBV infection in younger populations.
This study supports SDG 3 by developing predictive tools for treatment outcomes in chronic hepatitis B patients.
This study supports SDG 3 by investigating the relationship between NAFLD and liver fibrosis in chronic hepatitis B patients.
Access to information is critical in achieving the SDGs - empowering the public to make decisions, informing policy making and enabling effective implementation and monitoring. RELX businesses regularly produce and publish free to download reports and analytics that draw upon vast amounts of information and data in support of the SDGs. Explore some of the reports and tools developed to date.
